However, when the risk of CARPA pre-activation coincides with the substantial release of inflammatory mediators (IL-1β, IL-18) induced by sonodynamic therapy, this “coordinated immune activation” may escalate into a catastrophic and life-threatening cytokine release syndrome (CRS). The gene discussed is IL18; the disease is congenital rubella syndrome.